Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Improvements in overall survival have been observed with the introduction of rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), however, prognostic markers ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Lasse Sommer, Asmar, Fazila, Dimopoulos, Konstantinos, Nygaard, Mette Kathrine, Aslan, Derya, Hansen, Jakob Werner, Ralfkiaer, Elisabeth, Grønbæk, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259438/
https://www.ncbi.nlm.nih.gov/pubmed/25229255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259438/
https://www.ncbi.nlm.nih.gov/pubmed/25229255

Ejemplares similares